Skip to main content
Signal8
MOULDER LEON O JR profile photo

Leon O. Moulder Jr.

CIK: 0001228865

Transaction Breakdown

Open Market Buys (P)17 (65.4%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (19.2%)

Compensation grants

Other (G, F, J, C, D, …)4 (15.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Zai Lab Ltd logo
ZLAB

Zai Lab Ltd

Director
Zenas BioPharma, Inc. logo
ZBIO

Zenas BioPharma, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (26 total)

  • Zai Lab Ltd logo
    ZLAB

    Zai Lab Ltd

    Jun 17, 2026
    Award(A)
    Direct
    22.4K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jun 15, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    500K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    May 18, 2026
    Purchase(P)
    Indirect
    60K shares at avg. $16.88$1.0M
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Apr 29, 2026
    Purchase(P)
    Indirect
    35K shares at avg. $17.62$617K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Apr 28, 2026
    Purchase(P)
    Indirect
    25K shares at avg. $18.02$451K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Feb 2, 2026
    Purchase(P)
    Direct
    57K shares at avg. $17.96$1.0M
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jan 9, 2026
    Purchase(P)
    Direct
    20K shares at avg. $16.55$331K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jan 8, 2026
    Purchase(P)
    Direct
    30K shares at avg. $16.30$489K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jan 7, 2026
    Purchase(P)
    Direct
    50K shares at avg. $16.38$819K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Oct 7, 2025
    Purchase(P)
    Indirect
    36.9K shares at avg. $20.85$770K
  • Zai Lab Ltd logo
    ZLAB

    Zai Lab Ltd

    Jun 18, 2025
    Award(A)
    Direct
    10.8K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Jun 10, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    400K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Feb 18, 2025
    Purchase(P)
    Direct
    25K shares at avg. $6.67$167K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Dec 4, 2024
    Purchase(P)
    Direct
    45K shares at avg. $9.98$449K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Dec 3, 2024
    Purchase(P)
    Direct
    25K shares at avg. $10.76$269K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Nov 19, 2024
    Purchase(P)
    Direct
    2.5K shares at avg. $14.57$36K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Nov 18, 2024
    Purchase(P)
    Direct
    7.5K shares at avg. $15.00$113K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 20, 2024
    Purchase(P)
    Indirect
    2.4K shares at avg. $17.88$42K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 20, 2024
    Purchase(P)
    Indirect
    2.6K shares at avg. $18.97$50K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 19, 2024
    Purchase(P)
    Indirect
    5K shares at avg. $17.89$89K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 18, 2024
    Purchase(P)
    Indirect
    10K shares at avg. $17.91$179K
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 16, 2024
    Conversion(C)
    Indirect
    372K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 16, 2024
    Conversion(C)
    Indirect
    164.5K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 16, 2024
    Conversion(C)
    Direct
    48.3K shares-
  • Zenas BioPharma, Inc. logo
    ZBIO

    Zenas BioPharma, Inc.

    Sep 16, 2024
    Conversion(C)
    Direct
    108.4K shares-

1-25 of 26

About MOULDER LEON O JR

MOULDER LEON O JR (SEC CIK 0001228865) files insider reports with the SEC as Director of Zai Lab Ltd (ZLAB) and Director of Zenas BioPharma, Inc. (ZBIO).

Signal8 holds 16 ownership filings by MOULDER LEON O JR (1 Form 3, 15 Form 4), filed between Sep 12, 2024 and Jun 22, 2026. Those filings report 26 transactions, from Sep 12, 2024 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on MOULDER LEON O JR's filings is in WALTHAM, MA.

Recent filings by MOULDER LEON O JR

  • Jun 17, 2026: Grant or award of ZLAB shares (Form 4, code A).
  • Jun 15, 2026: Grant or award of ZBIO derivative securities (Form 4, code A).
  • May 18, 2026: Open-market purchase of ZBIO shares (Form 4, code P).
  • Apr 29, 2026: Open-market purchase of ZBIO shares (Form 4, code P).
  • Apr 28, 2026: Open-market purchase of ZBIO shares (Form 4, code P).

Other insiders filing for Zai Lab Ltd (ZLAB)

How to read Form 4 transaction codes